Nalaganje...
Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial
<p>Abstract</p> <p>Background</p> <p>Late onset neonatal sepsis (LOS) with the mortality of 17 to 27% is still a serious disease. Meropenem is an antibiotic with wide antibacterial coverage. The advantage of it over standard of care could be its wider antibacterial cove...
Shranjeno v:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2011-09-01
|
| Serija: | Trials |
| Teme: | |
| Online dostop: | http://www.trialsjournal.com/content/12/1/215 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|